The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Change in CEA as an early predictor of progression to first-line systemic therapy in metastatic colorectal cancer.
 
Pat Gulhati
No Relationships to Disclose
 
Jun Yin
No Relationships to Disclose
 
Levi Pederson
No Relationships to Disclose
 
Hans-Joachim Schmoll
Honoraria - Roche; SERVIER
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Roche
Research Funding - GlaxoSmithKline; Roche
Travel, Accommodations, Expenses - Bayer; Roche; SERVIER
 
Paulo Marcelo Hoff
Consulting or Advisory Role - AstraZeneca (I); Bayer (I)
Research Funding - Roche/Genentech
 
Jean-Yves Douillard
No Relationships to Disclose
 
J. Randolph Hecht
No Relationships to Disclose
 
Christophe Tournigand
Honoraria - Bayer; Lilly; Roche; Sanofi
Consulting or Advisory Role - Lilly; Sandoz
Research Funding - Roche
Travel, Accommodations, Expenses - Bayer; Pfizer; Roche; Sanofi
 
Niall Tebbut
No Relationships to Disclose
 
Benoist Chibaudel
No Relationships to Disclose
 
Aimery De Gramont
Honoraria - Chugai Pharma; Yakult Pharmaceutical
 
Qian Shi
No Relationships to Disclose
 
Michael J. Overman
Consulting or Advisory Role - Bristol-Myers Squibb; Merrimack; Roche/Genentech
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; MedImmune; Merck; Roche